Magle PharmaCept is committed to improving health for patients. It is our absolute commitment to ensure we supply high-quality products to patients, and healthcare professionals. Our emphasis is on conducting research and providing healthcare professionals with scientific evidence.
Magle PharmaCept continuously strives to innovate and bring life changing solutions to patients in need. Magle PharmaCept collaborates with healthcare professionals and research institutions to develop products and solutions to offer patients optimal therapy options.
The company PharmaCept was founded in 1999 with a strong belief that better therapies will improve the quality of life for patients. In 2021, when PharmaCept celebrated 22 years, Magle Group acquired PharmaCept, becoming Magle PharmaCept.
Magle PharmaCept is always looking ahead, exploring new avenues for research and development. With a team of dedicated professionals and a commitment to excellence, it is determined to continue developing new products for innovative therapies, improving the lives of patients.
Join us to gain deeper insight into our DSM technology and product portfolio and be part of a community driving positive change in healthcare.
At Magle PharmaCept, we recognize the significance of clinical research in ensuring the safe and effective use of our products. With an evidence-based approach, we are committed to meaningful evidence, leveraging clinical data and outcomes research.
The science where we can make the most difference, now and in the future, is where we focus our efforts.
DSM technology creates solutions for patients and providers by leveraging cutting-edge technology and medical research. By combining different formulations with different active ingredients, DSM can be used to address currently unmet medical needs, providing patients and health care professional with effective and innovative treatment options.